Atlas Trials

Locally Advanced or Metastatic Non-Small Cell Lung Cancer

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Locally Advanced or Metastatic Non-Small Cell Lung Cancer

RecordFirmDate
A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors (NCT04996121)Xuanzhu Biopharmaceutical Co., Ltd.2021-12-06
Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer (NCT05132777)Shanghai JMT-Bio Inc.2021-11-20
A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations (NCT05048797)AstraZeneca2021-10-28
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC (NCT04686305)AstraZeneca2021-03-09
Study of PF-07248144 in Advanced or Metastatic Solid Tumors (NCT04606446)Pfizer2020-11-16
Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer (NCT04448379)Shanghai JMT-Bio Inc.2020-06-29
Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients (NCT01526928)Clovis Oncology, Inc.2012-03-27

Track Locally Advanced or Metastatic Non-Small Cell Lung Cancer automatically

Every clearance here is in the API, with alerts when new ones post.